"10.1371_journal.pone.0078696","plos one","2013-11-11T00:00:00Z","Gines Escolar; Victor Fernandez-Gallego; Eduardo Arellano-Rodrigo; Jaume Roquer; Joan Carles Reverter; Victoria Veronica Sanz; Patricia Molina; Irene Lopez-Vilchez; Maribel Diaz-Ricart; Ana Maria Galan","Department of Hemotherapy-Hemostasis, Hospital Clinic, Centre de Diagnostic Biomedic, Institut dInvestigacions Biomediques August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain; Bristol-Myers Squibb, Madrid, Spain; Department of Neurology, Hospital Universitari del Mar, Parc de Salut Mar, Barcelona, Spain","Conceived and designed the experiments: GE VFG MDR AMG. Performed the experiments: EAR JR JCR VVS PM ILV. Analyzed the data: GE VFG EAR JR JCR VVS PM ILV MDR AMG. Wrote the paper: GE VFG EAR JR JCR VVS PM ILV MDR AMG.","This work was partially supported by an investigator sponsored award from BMS-Pfizer. Fernandez-Gallego V is employed by Bristol-Myers Squibb, the producer of Apixaban. Gines Escolar has received honoraria/consultant fees from Bayer, BMS, Boehringer Ingelheim, CSL Behring and NovoNordisk. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","11","Gines Escolar","GE",10,TRUE,4,6,10,10,TRUE,TRUE,FALSE,0,NA,FALSE
